TipRanks
Advertisement
Advertisement

SHPHF Stock Latest News

Sihuan Pharmaceutical Expands Dongyan Skin Booster Dosage Range to Strengthen Aesthetics Portfolio
Company AnnouncementsSihuan Pharmaceutical Expands Dongyan Skin Booster Dosage Range to Strengthen Aesthetics Portfolio
2d ago
Sihuan’s Xuanzhu Biopharm Strikes Exclusive Bireociclib Deal in Thailand
PremiumCompany Announcements
Sihuan’s Xuanzhu Biopharm Strikes Exclusive Bireociclib Deal in Thailand
1M ago
Sihuan Pharmaceutical Grants 116 Million Performance-Based Share Awards
PremiumCompany Announcements
Sihuan Pharmaceutical Grants 116 Million Performance-Based Share Awards
1M ago
Sihuan Pharma Launches Share Buyback as Profit Surges on Aesthetics Push
PremiumCompany Announcements
Sihuan Pharma Launches Share Buyback as Profit Surges on Aesthetics Push
1M ago
Sihuan Pharmaceutical Reshapes Leadership With CFO Exit and New Non-Executive Director
PremiumCompany Announcements
Sihuan Pharmaceutical Reshapes Leadership With CFO Exit and New Non-Executive Director
1M ago
Sihuan Pharmaceutical Clarifies Board and Committee Structure
PremiumCompany AnnouncementsSihuan Pharmaceutical Clarifies Board and Committee Structure
1M ago
Sihuan Pharmaceutical Leans on Aesthetics and Innovation as Generic Drug Margins Erode
Premium
Company Announcements
Sihuan Pharmaceutical Leans on Aesthetics and Innovation as Generic Drug Margins Erode
1M ago
Sihuan Pharmaceutical Sets Board Meeting to Approve Interim Results and Dividend Plan
Premium
Company Announcements
Sihuan Pharmaceutical Sets Board Meeting to Approve Interim Results and Dividend Plan
2M ago
Sihuan Pharmaceutical Updates Bermuda Registered Office Address
PremiumCompany Announcements
Sihuan Pharmaceutical Updates Bermuda Registered Office Address
2M ago
Sihuan Pharmaceutical Flags 217% Profit Surge on Medical Aesthetics and Portfolio Gains
PremiumCompany Announcements
Sihuan Pharmaceutical Flags 217% Profit Surge on Medical Aesthetics and Portfolio Gains
2M ago
Sihuan’s Xuanzhu Wins NMPA NDA Acceptance for New Reflux Esophagitis Use of Anaprazole
PremiumCompany Announcements
Sihuan’s Xuanzhu Wins NMPA NDA Acceptance for New Reflux Esophagitis Use of Anaprazole
3M ago
Sihuan Pharmaceutical Shareholders Approve All AGM Resolutions and Capital Mandates
PremiumCompany Announcements
Sihuan Pharmaceutical Shareholders Approve All AGM Resolutions and Capital Mandates
3M ago
Sihuan’s Xuanzhu Biopharm Launches Phase III Trial for Anaprazole in H. pylori Therapy
PremiumCompany AnnouncementsSihuan’s Xuanzhu Biopharm Launches Phase III Trial for Anaprazole in H. pylori Therapy
4M ago
Sihuan Pharmaceutical Buys Shares for Award Scheme as Medical Aesthetics Surges
Premium
Company Announcements
Sihuan Pharmaceutical Buys Shares for Award Scheme as Medical Aesthetics Surges
4M ago
Sihuan Pharmaceutical Buys Shares for Award Scheme as Medical Aesthetics Drives Profitable Growth
Premium
Company Announcements
Sihuan Pharmaceutical Buys Shares for Award Scheme as Medical Aesthetics Drives Profitable Growth
4M ago
Sihuan Pharmaceutical Sets 2026 AGM to Approve FY2025 Results, Dividend and Share Issuance Mandate
PremiumCompany Announcements
Sihuan Pharmaceutical Sets 2026 AGM to Approve FY2025 Results, Dividend and Share Issuance Mandate
4M ago
Sihuan Pharmaceutical Forms AI-Driven Medical Aesthetics JV with dProtein
PremiumCompany Announcements
Sihuan Pharmaceutical Forms AI-Driven Medical Aesthetics JV with dProtein
4M ago
Sihuan Pharma Buys Shares for Award Scheme as Medical Aesthetics Drives Profit Turnaround
PremiumCompany Announcements
Sihuan Pharma Buys Shares for Award Scheme as Medical Aesthetics Drives Profit Turnaround
4M ago
Sihuan Pharmaceutical Launches Share Buyback as Medical Aesthetics Surge Drives Return to Profit
PremiumCompany Announcements
Sihuan Pharmaceutical Launches Share Buyback as Medical Aesthetics Surge Drives Return to Profit
5M ago
Sihuan Pharma Launches Share Buyback as Medical Aesthetics Surges
PremiumCompany AnnouncementsSihuan Pharma Launches Share Buyback as Medical Aesthetics Surges
5M ago
Sihuan’s Xuanzhu Biopharm Completes Full H Share Circulation in Hong Kong
Premium
Company Announcements
Sihuan’s Xuanzhu Biopharm Completes Full H Share Circulation in Hong Kong
5M ago
Sihuan Pharma Uses Share Award Buy to Back Profitable Growth in Aesthetics and Biopharma
Premium
Company Announcements
Sihuan Pharma Uses Share Award Buy to Back Profitable Growth in Aesthetics and Biopharma
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >